Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001346302-18-000025
Filing Date
2018-11-08
Accepted
2018-11-08 08:28:41
Documents
59
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q q32018form10-q.htm 10-Q 1207454
2 EXHIBIT 10.1 q32018exhibit101.htm EX-10.1 303976
3 EXHIBIT 31.1 q32018exhibit311.htm EX-31.1 13596
4 EXHIBIT 31.2 q32018exhibit312.htm EX-31.2 13672
5 EXHIBIT 32.1 q32018exhibit321.htm EX-32.1 10490
12 shlxeris.jpg GRAPHIC 12479
  Complete submission text file 0001346302-18-000025.txt   4670352

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT xers-20180930.xml EX-101.INS 696861
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xers-20180930.xsd EX-101.SCH 35717
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xers-20180930_cal.xml EX-101.CAL 28566
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xers-20180930_def.xml EX-101.DEF 162426
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xers-20180930_lab.xml EX-101.LAB 413366
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xers-20180930_pre.xml EX-101.PRE 245751
Mailing Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601 512-498-2670
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

EIN.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38536 | Film No.: 181168291
SIC: 2834 Pharmaceutical Preparations